| Filed On | Filing |
|---|---|
| 09 Oct 2026 | APPLICATION FOR DEREGISTRATION MADE ON FORM N-8F |
| 24 Sep 2026 | N-CEN/A |
| 04 Sep 2026 | APPLICATION FOR DEREGISTRATION MADE ON FORM N-8F |
| 01 Sep 2026 |
Form 4: Jefferies John, Chief Medical Officer
Received 2,451 shares as a grant or award |
| 31 Aug 2026 | NPORT-P |
| 31 Aug 2026 | N-CSR |
| 31 Aug 2026 | N-PX |
| 25 Jun 2026 |
Form 4: Michel Robert J, Chief Financial Officer
Received 12,000 shares as a grant or award |
| 25 Jun 2026 |
Form 4: Feldschuh Michael Richard, Director
Received 30,000 shares as a grant or award |
| 25 Jun 2026 |
Form 4: Feldschuh Jonathan Adam, Director
Received 25,000 shares as a grant or award |
| 25 Jun 2026 |
Form 4: Goudie Joy S., Director
Granted 2,500 Stock Options (right to buy) |
| 25 Jun 2026 |
Form 4: Cremisi Henry D., Director
Granted 2,500 Stock Options (right to buy) |
| 25 Jun 2026 |
Form 4: Feuer Edward, Director
Granted 2,500 Stock Options (right to buy) |
| 25 Jun 2026 |
Form 4: DesRosiers Caleb, Director
Granted 2,500 Stock options (right to buy) |
| 24 Jun 2026 | 8-K: Submission of Matters to a Vote of Security Holders |
| 17 Jun 2026 | 40-8F-2/A |
| 03 Jun 2026 | Proxy statement: annual meeting on June 23, 2026 |
| 02 Jun 2026 | NT NPORT-P |
| 21 May 2026 | 40-8F-2/A |
| 11 May 2026 | 40-17F2 |
Loading...
